Find anything about our product, search our documentation, and more. Enter a query in the search input above, and results will be displayed as you type.
Searching... 
Global Life Science and Healthcare
We help companies advancing the future of healthcare scale effectively at every stage of growth.
Our Expertise
Biopharma
Healthtech
Medical Devices
Healthcare Services
Diagnostics and Tools
We work with companies just like yours
Our clients consist of the top companies and investors across key sectors of life sciences and healthcare.
*All companies listed above are independent third parties and not affiliated with SVB Financial Group.
Dedicated team
Your partner in driving the future of healthcare
Our global footprint gives you access to market insights, investors and financial solutions on your path to growth.
Katherine Andersen
|
Head of Life Science and Healthcare
Katherine serves as the Head of Life Science and Healthcare and sits on the board of SVB's joint venture in China, SPD Silicon Valley Bank.
Keith Cox
|
Head of Leveraged Finance and Sponsor Coverage
Keith Cox is the Head of Leveraged Finance and Sponsor Coverage for Silicon Valley Bank in Boston, Massachusetts.
Gregory Pachus
|
Head of Business Development, Healthcare Leveraged Finance and Corporate Banking
Greg leads SVB’s Healthcare Leveraged Finance and Sponsor Coverage practice which supports companies’ complex financing needs and middle market private equity investors.
Christopher Moniz
|
Market Manager, HealthTech and Devices
Chris is the director of SVB's Life Science and Healthcare practice specializing in healthcare IT and device companies.
Kate Walsh
|
Market Manager, Biopharma, Tools and Diagnostics
Kate is the Head of Biopharma, Tools and Diagnostics for the Northeast and San Francisco Bay Area markets.
Laura Scott
|
Senior Market Manager, Business Planning and Head of Mid-Atlantic and Southeast
Laura leads business planning for SVB's Life Science and Healthcare practice and oversees business development and relationship management in the Mid-Atlantic and Southeast markets.
Tom Hertzberg
|
Market Manager, Central and Southwest
Tom is the Head of SVB's Central US Life Science and Healthcare Banking, where he connects life-changing healthcare ideas with capital.
Ben Johnson
|
Head of Early Stage
Ben leads SVB’s seed stage life science and healthcare effort in the US, spending his time building relationships with early stage companies and key forces in the healthcare ecosystem.
Jennifer Friel Goldstein
|
Managing Partner, Life Science and Healthcare, SVB Capital
Jennifer is the managing partner for Life Science and Healthcare at SVB Capital with more than 20 years of experience in the VC and startup market segments.
Anne Woods
|
Managing Director, Life Science and Healthcare
Anne leads SVB’s relationship with companies in Canada’s life science market and thrives on supporting these companies as they influence the next breakthrough.
Healthcare innovators
We partner with the most innovative life science and healthcare companies to help them move their bold ideas forward.
BIOPHARMA
Mythic Therapeutics
Working together to target cancer
- “Silicon Valley Bank has been a great partner to us from the company’s earliest days, and our relationship has only evolved as we’ve grown. The team is courteous, respectful and has high-integrity. I would recommend them to any entrepreneur.”
Alex Nichols
President and CEO, Mythic Therapeutics
HEALTHTECH
Aledade
Improving healthcare, growing strong
- “SVB understands the complexities of our business and industry. They developed customized financing solutions for us, so we can keep our focus on helping physicians across the country deliver better care for their patients. We are thrilled with the results.”
Farzad Mostashari, M.D.
Founder and CEO, Aledade
BIOPHARMA
DICE Therapeutics
Pivoting for promise in psoriasis treatment
- “Silicon Valley Bank and SVB Securities provide us with the financial services and support needed to accelerate our growth.”
Kevin Judice
CEO, DICE Therapeutics
MEDICAL DEVICE
Activ Surgical
Innovating a cutting-edge surgical tool
- “We’ve relied on SVB as our banking partner for years, and we were very pleased with the runway capital solutions they provided to take Activ to the next level. SVB knows us, the industry and our business.”
Todd Usen
CEO, Activ Surgical
DIAGNOSTICS AND TOOLS
Xilis
Micro-tumor production grows hope in the fight against cancer
- “SVB has been a valued partner in our path to growth, coming in with the financial backing at the early stage enabling us to bring the vision of MicroOrganoSphere technology to life.”
Xiling Shen, Ph.D.
Co-founder and CEO, Xilis
Healthtech
Privia Health
Building primary care centric delivery care networks
- “SVB has a deep understanding of our unique needs and where we sit in the healthcare ecosystem. The SVB team has in-depth knowledge of the healthcare industry and, in particular, the provider space we operate in. Bringing all those things together while providing us with differentiated solutions and ideas is what we really value in our partnership.”
Parth Mehrotra
President and COO, Privia Health
Grow with confidence
The financial stress of unpredictable development timelines, regulations and reimbursement cycles can stand in the way of innovation and growth. SVB has the insights, guidance and resources to help you scale effectively at every stage of growth.
Connect to the global SVB network
- Meet the VCs we work with
- Find your next hire through SVB's exclusive job board
- Get introduced to specialized service providers
Investment Banking
- Define and achieve your strategic, capital markets and investment objectives with support from SVB Securities
- Benefit from market intelligence and strategic advice
- Form connections with management teams and institutional investors
CipherBio
- Access to investing data based on indications
- Access to discover and navigate the life science ecosystem
- Ability to explore how your science is interconnected
SVB in China
Diversity, Equity and Inclusion Forum
- Access ideas from DE&I leaders
- Discover highly-relevant presentations
- Participate in the conversation
Strategies for Growth Beyond Series A: eBook
They understand the value of relationships. They wanted my business when Twist was nobody.
Sophisticated solutions tailored to your lifestage
SVB Startup Banking
The banking, tools and access to reach your next round faster.
Learn more
Investment Banking
Investment banking specialized in healthcare and life sciences.
Learn more
SVB Asset Management
Helping high-growth clients achieve their investment objectives through exercising fiduciary care as a trusted advisor.
Learn more
Ready to get started?
See how SVB can help your business scale confidently for growth.
Insights from SVB Industry Experts
Proprietary insights to keep leaders on the cutting-edge of their sector and industry.
Report
Healthcare Investments and Exits
SVB's Healthcare Investments and Exits Annual 2022 review examines trends and analysis for biopharma, healthtech, dx/tools, and device. Download to read the report.
Event
Healthcare Investments and Exits: Strong Venture Fundraising for Healthcare During Times of Uncertainty
Join Mira Chaurushiya, Ph.D, Senior Partner, Westlake Village BioPartners; Deena Shakir, Partner, Lux Capital; Jon Norris, Managing Director, Healthcare at SVB; and moderator Sarah Pringle, Health Tech Reporter, Axios as they discuss the latest healthcare trends and insights from SVB’s Healthcare Investments and Exits Mid-Year 2022 review.
Blog | Life Science & Healthcare
SVB's 2022 healthtech report reveals strong investment opportunity in mental health
Promising developments in mental health are leading to increases in deal sizes, valuations and M&A activity across the healthtech industry.
News | July 11, 2022
Report
Healthcare Investments and Exits Mid-Year 2022
SVB's Healthcare Investments and Exits Mid-Year 2022 review examines trends and analysis for biopharma, healthtech, dx/tools, and device. Download to read the report.
Event
Healthcare Investments and Exits: Reshaping Healthcare After Covid-19
The pandemic created enormous disruption across the global economy. But few industries felt it more than healthcare — and life science innovators everywhere have responded to the challenge. Join SVB as we discuss and take questions on our latest Healthcare Investments and Exits Report.
Blog | Life Science & Healthcare
Healthcare Trends 1H2022: Insights and advice for founders
The healthcare industry continues to see strong investor fundraising activity despite a difficult public market and a slow decline in valuations.
News | July 11, 2022
Report
Healthcare Investments and Exits Annual 2021 Report
Discover the annual 2021 outcomes for healthcare investments and exits in the latest January 2022 edition. Healthcare venture fundraising almost doubled in 2021 over the previous year, with phenomenal growth across sectors: biopharma, healthtech, Dx/tools and device. Read the timely report now.
Get regular updates from SVB’s healthcare practice